Notably, Grb-14 (GRB14) and PTP1B (PTPN1) are known molecular constituents of insulin resistance [43,44] and development of PTP1B inhibitors for therapeutic modulation of insulin sensitivity is an active field of research [45]. Here, INS is linked to Insulin resistance.